DistantNews
Support us
Kim Ha-seong labeled 'worst signing of the season,' compared to 'drug-cheat' player
๐Ÿ‡ฐ๐Ÿ‡ท South Korea /Sports

Kim Ha-seong labeled 'worst signing of the season,' compared to 'drug-cheat' player

From Chosun Ilbo · () Korean

Translated from Korean, summarized and contextualized by DistantNews.

At a glance

News Named sources Context piece
  • Korean player Ha-Seong Kim has been labeled the worst offseason acquisition by Atlanta Braves, according to HTHB.
  • The publication compared Kim's performance to that of a "drug-suspended" player, highlighting his struggles.
  • Kim's injury issues have also been downplayed by the outlet.

Korean baseball player Ha-Seong Kim is facing harsh criticism, with one outlet labeling him the "worst offseason acquisition" by the Atlanta Braves. HTHB, which covers Atlanta news, issued a scathing review of Kim's performance, suggesting there would be "no disagreement" among Braves fans about this assessment.

The publication did not hold back in its critique, drawing a stark comparison between Kim and a player who faced disciplinary action for performance-enhancing drugs. This comparison implies that Kim's struggles on the field are so severe that he is now being evaluated in the same category as a "drug-suspended" player, often referred to as a "swindler" or "money-grabber" in Korean sports contexts.

Furthermore, HTHB reportedly downplayed any injury concerns that might explain Kim's poor performance. While fans and media might typically consider player injuries when evaluating performance, the outlet seems to dismiss these factors, focusing instead on what it perceives as Kim's fundamentally subpar play. The article suggests that while Atlanta fans might be preoccupied with other team issues, such as the struggles of Austin Riley or the injury to Drew Baldwin, Kim's performance has been "unbelievably poor."

DistantNews Editorial

Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.